Get the latest Science News and Discoveries

GLP-1 Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials

None

Get the Android app

Or read this on New York Times

Read more on:

Photo of Alzheimer

Alzheimer

Photo of ozempic drug

ozempic drug

Photo of novo nordisk trials

novo nordisk trials

Related news:

GLP-1 Pill Fails to Slow Alzheimer’s Progression in Clinical Trial

3,000 steps per day might slow Alzheimer’s disease

Inspired by a family’s struggle, a scientist helps uncover defense against Alzheimer’s disease - EurekAlert!

« China's rising influence in space prompts Senate to call for new US research institute in post-ISS era

Suppressing DBNDD2 promotes neuron growth and axon regeneration in adult mammals - EurekAlert! »